JP2016518341A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518341A5
JP2016518341A5 JP2016503301A JP2016503301A JP2016518341A5 JP 2016518341 A5 JP2016518341 A5 JP 2016518341A5 JP 2016503301 A JP2016503301 A JP 2016503301A JP 2016503301 A JP2016503301 A JP 2016503301A JP 2016518341 A5 JP2016518341 A5 JP 2016518341A5
Authority
JP
Japan
Prior art keywords
compound according
compound
item
label
fluorescent label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503301A
Other languages
English (en)
Japanese (ja)
Other versions
JP6490660B2 (ja
JP2016518341A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/029990 external-priority patent/WO2014145257A2/en
Publication of JP2016518341A publication Critical patent/JP2016518341A/ja
Publication of JP2016518341A5 publication Critical patent/JP2016518341A5/ja
Application granted granted Critical
Publication of JP6490660B2 publication Critical patent/JP6490660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503301A 2013-03-15 2014-03-15 活性に基づくプローブの化合物、組成物、および使用方法 Active JP6490660B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794296P 2013-03-15 2013-03-15
US61/794,296 2013-03-15
PCT/US2014/029990 WO2014145257A2 (en) 2013-03-15 2014-03-15 Activity-based probe compounds, compositions, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034163A Division JP2019081791A (ja) 2013-03-15 2019-02-27 活性に基づくプローブの化合物、組成物、および使用方法

Publications (3)

Publication Number Publication Date
JP2016518341A JP2016518341A (ja) 2016-06-23
JP2016518341A5 true JP2016518341A5 (cg-RX-API-DMAC7.html) 2017-04-20
JP6490660B2 JP6490660B2 (ja) 2019-03-27

Family

ID=51538442

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016503301A Active JP6490660B2 (ja) 2013-03-15 2014-03-15 活性に基づくプローブの化合物、組成物、および使用方法
JP2019034163A Withdrawn JP2019081791A (ja) 2013-03-15 2019-02-27 活性に基づくプローブの化合物、組成物、および使用方法
JP2021005558A Withdrawn JP2021059606A (ja) 2013-03-15 2021-01-18 活性に基づくプローブの化合物、組成物、および使用方法
JP2023060174A Active JP7689753B2 (ja) 2013-03-15 2023-04-03 活性に基づくプローブの化合物、組成物、および使用方法
JP2025084936A Pending JP2025124721A (ja) 2013-03-15 2025-05-21 活性に基づくプローブの化合物、組成物、および使用方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019034163A Withdrawn JP2019081791A (ja) 2013-03-15 2019-02-27 活性に基づくプローブの化合物、組成物、および使用方法
JP2021005558A Withdrawn JP2021059606A (ja) 2013-03-15 2021-01-18 活性に基づくプローブの化合物、組成物、および使用方法
JP2023060174A Active JP7689753B2 (ja) 2013-03-15 2023-04-03 活性に基づくプローブの化合物、組成物、および使用方法
JP2025084936A Pending JP2025124721A (ja) 2013-03-15 2025-05-21 活性に基づくプローブの化合物、組成物、および使用方法

Country Status (7)

Country Link
US (4) US10100037B2 (cg-RX-API-DMAC7.html)
EP (2) EP4218829A3 (cg-RX-API-DMAC7.html)
JP (5) JP6490660B2 (cg-RX-API-DMAC7.html)
KR (1) KR102279618B1 (cg-RX-API-DMAC7.html)
CN (2) CN120132004A (cg-RX-API-DMAC7.html)
ES (1) ES2938225T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014145257A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4218829A3 (en) * 2013-03-15 2023-08-16 The Board of Trustees of the Leland Stanford Junior University Activity-based probe compounds, compositions, and methods of use
EP3204352B1 (en) 2014-10-06 2020-07-01 Cortexyme, Inc. Inhibitors of lysine gingipain
CN107406872B (zh) * 2015-01-22 2023-03-28 里兰斯坦福初级大学理事会 用于标记动物组织的化合物、组合物及其应用
EP3374352A4 (en) 2015-11-09 2019-10-02 Cortexyme, Inc. GINGIPAINE ARGININE INHIBITORS
IL265389B1 (en) 2016-09-16 2026-07-01 Quince Therapeutics Inc Ketone compounds lysine inhibitors gingerapine, preparations containing them and uses thereof
WO2018071556A1 (en) 2016-10-11 2018-04-19 The Regents Of The University Of California Detection, identification, and purification of degradative and non-degradative enzymes in biological samples
CN116217656B (zh) * 2016-12-23 2026-05-08 里兰斯坦福初级大学理事会 基于活性的探针化合物、组合物及其使用方法
CN110678460A (zh) * 2017-03-30 2020-01-10 里兰斯坦福初级大学理事会 用于体内成像的蛋白酶激活的造影剂
WO2018200592A1 (en) 2017-04-24 2018-11-01 Regents Of The University Of California Biosynthesis of bioorthogonal amino acids
EP3717019A4 (en) * 2017-11-28 2021-09-22 Board of Regents of the University of Nebraska RADIOPHARMACEUTICALS AND METHOD OF USE THEREOF
WO2020028396A1 (en) 2018-07-30 2020-02-06 Georgetown University Chirality sensing with molecular click chemistry probes
US11860084B2 (en) 2018-09-11 2024-01-02 Georgetown University Quantitative auxiliary-free chirality sensing with a metal probe
CA3120758A1 (en) * 2018-12-20 2020-06-25 Takeda Pharmaceutical Company Limited Novel activity-based probes for neutrophil elastase and their use
CA3120756A1 (en) * 2018-12-20 2020-06-25 Takeda Pharmaceutical Company Limited Sulfoxonium ylide derivatives as probes for cysteine protease

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5055451A (en) 1986-12-22 1991-10-08 Syntex Inc. Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
WO1996041638A1 (en) 1995-06-13 1996-12-27 Sanofi Winthrop, Inc. Calpain inhibitors for the treatment of neurodegenerative diseases
US5989823A (en) 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US6197750B1 (en) 1998-07-02 2001-03-06 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US6544951B2 (en) * 1998-07-02 2003-04-08 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
WO2000064988A1 (en) 1999-04-23 2000-11-02 Molecular Probes, Inc. Xanthene dyes and their application as luminescence quenching compounds
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US20020052323A1 (en) * 2000-08-30 2002-05-02 Jinhai Wang Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents
GB0112868D0 (en) 2001-05-25 2001-07-18 Secr Defence Detection system
US20050014160A1 (en) 2003-07-18 2005-01-20 Sriram Kumaraswamy Assays for protease enzyme activity
US8968700B2 (en) 2005-08-11 2015-03-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging of protease activity in live cells using activity based probes
US8343458B2 (en) 2008-04-03 2013-01-01 The Board Of Trustees Of The Leland Stanford Junior University Probes for in vivo targeting of active cysteine proteases
WO2012021800A2 (en) * 2010-08-13 2012-02-16 Banyan Biomarkers Caspase inhibitors as therapeutics for neural and organ injury and imaging
US9180209B2 (en) * 2011-02-28 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes
WO2014152389A1 (en) 2013-03-14 2014-09-25 Lumicell, Inc. Imaging agent for detection of diseased cells
EP4218829A3 (en) * 2013-03-15 2023-08-16 The Board of Trustees of the Leland Stanford Junior University Activity-based probe compounds, compositions, and methods of use
CN116217656B (zh) * 2016-12-23 2026-05-08 里兰斯坦福初级大学理事会 基于活性的探针化合物、组合物及其使用方法

Similar Documents

Publication Publication Date Title
JP2018511556A5 (cg-RX-API-DMAC7.html)
Nogales et al. A novel fluorescent and bioluminescent bireporter influenza A virus to evaluate viral infections
JP2019514426A5 (cg-RX-API-DMAC7.html)
RU2020136402A (ru) Пирролопирроловые композиции в качестве активаторов пируваткиназы (pkr)
JP2018504378A5 (cg-RX-API-DMAC7.html)
JP2017536344A5 (cg-RX-API-DMAC7.html)
JP2018504379A5 (cg-RX-API-DMAC7.html)
JP2012506703A5 (cg-RX-API-DMAC7.html)
JP2018507197A5 (cg-RX-API-DMAC7.html)
EP4541378A3 (en) Compounds for positron emission tomography
JP2016153410A5 (cg-RX-API-DMAC7.html)
JP2012518029A5 (cg-RX-API-DMAC7.html)
JP2014177455A5 (cg-RX-API-DMAC7.html)
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
JP2010527913A5 (cg-RX-API-DMAC7.html)
EA201290659A1 (ru) Новая композиция ретигабина
EP4310504A3 (en) Activity-based probe compounds, compositions, and methods of use
JP2017533886A5 (cg-RX-API-DMAC7.html)
SG10201807904RA (en) Mitochondria-Targeted Dicarbonyl Sequestering Compounds
JP2020513050A5 (cg-RX-API-DMAC7.html)
DE602004023594D1 (de) Ein virus der infektiösen bronchitis mit veränderten spike-gen
Lee et al. Novel approaches in anti-arenaviral drug development
JP2019525922A5 (cg-RX-API-DMAC7.html)
JP2015502330A5 (cg-RX-API-DMAC7.html)
Shen et al. Prediction of traumatic avascular necrosis of the femoral head by single photon emission computerized tomography and computerized tomography: an experimental study in dogs